Description
KPV is a synthetic tripeptide (lysine-proline-valine) corresponding to the C-terminal end of alpha-melanocyte-stimulating hormone. Researchers study it as a candidate anti-inflammatory peptide.
In cultured cells and laboratory animals, investigations have focused on inflammatory cytokine control, NF-kB pathway signaling, intestinal epithelial responses, and repair-related activity. Its minimal three-residue structure makes it a clean probe for anti-inflammatory mechanisms.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.